Sound Biologics   Report issue

For profit Phase 1
Founded: Bothell WA United States (2015)

Organization Overview

First Clinical Trial
2019
NCT03986606
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Qilu Puget Sound Biotherapeutics | Qilu Puget Sound Biotherapeutics (dba Sound Biologics)

Active Ingredients

Drugs in Phase 1 Trials (3)

PSB102 (1 trial)

PSB107 (1 trial)

psb205 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 2
  • # of Trial APIs: 3